Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

420 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
An updated catalog of prostate cancer predictive tools.
Shariat SF, Karakiewicz PI, Roehrborn CG, Kattan MW. Shariat SF, et al. Among authors: roehrborn cg. Cancer. 2008 Dec 1;113(11):3075-99. doi: 10.1002/cncr.23908. Cancer. 2008. PMID: 18823041 Review.
Long-term patient survival after cystectomy for regional metastatic transitional cell carcinoma of the bladder.
Roehrborn CG, Sagalowsky AI, Peters PC. Roehrborn CG, et al. J Urol. 1991 Jul;146(1):36-9. doi: 10.1016/s0022-5347(17)37708-x. J Urol. 1991. PMID: 2056601
The assessment of medical treatment for benign prostatic hyperplasia (BPH).
Roehrborn CG. Roehrborn CG. Prog Clin Biol Res. 1994;386:175-90. Prog Clin Biol Res. 1994. PMID: 7528385 Review. No abstract available.
False-positive serum prostate-specific antigen values in a patient with non-Hodgkin lymphoma of the kidney.
Djavan B, Keffer JH, Molberg K, Roehrborn CG. Djavan B, et al. Among authors: roehrborn cg. Urology. 1995 May;45(5):875-8. doi: 10.1016/S0090-4295(99)80099-5. Urology. 1995. PMID: 7538247
The Agency for Health Care Policy and Research. Clinical guidelines for the diagnosis and treatment of benign prostatic hyperplasia.
Roehrborn CG. Roehrborn CG. Urol Clin North Am. 1995 May;22(2):445-53. Urol Clin North Am. 1995. PMID: 7539190
Radical retropubic prostatectomy for localized carcinoma of the prostate in a large metropolitan hospital: changing trends over a 10-year period (1984-1994). Dallas Outcomes Research Group for Urological Disorders.
Litwiller SE, Djavan B, Klopukh BV, Richier JC, Roehrborn CG. Litwiller SE, et al. Among authors: roehrborn cg. Urology. 1995 May;45(5):813-22. doi: 10.1016/s0090-4295(99)80089-2. Urology. 1995. PMID: 7747373 Clinical Trial.
Variability of repeated serum prostate-specific antigen (PSA) measurements within less than 90 days in a well-defined patient population.
Roehrborn CG, Pickens GJ, Carmody T 3rd. Roehrborn CG, et al. Urology. 1996 Jan;47(1):59-66. doi: 10.1016/s0090-4295(99)80383-5. Urology. 1996. PMID: 8560664
The Hytrin Community Assessment Trial study: a one-year study of terazosin versus placebo in the treatment of men with symptomatic benign prostatic hyperplasia. HYCAT Investigator Group.
Roehrborn CG, Oesterling JE, Auerbach S, Kaplan SA, Lloyd LK, Milam DE, Padley RJ. Roehrborn CG, et al. Urology. 1996 Feb;47(2):159-68. doi: 10.1016/s0090-4295(99)80409-9. Urology. 1996. PMID: 8607227 Clinical Trial.
Diagnostic yield of repeated transrectal ultrasound-guided biopsies stratified by specific histopathologic diagnoses and prostate specific antigen levels.
Roehrborn CG, Pickens GJ, Sanders JS. Roehrborn CG, et al. Urology. 1996 Mar;47(3):347-52. doi: 10.1016/s0090-4295(99)80451-8. Urology. 1996. PMID: 8633400
Is screening for prostate cancer necessary in men with symptoms of benign prostatic hyperplasia?
Hall MC, Roehrborn CG, McConnell JD. Hall MC, et al. Among authors: roehrborn cg. Semin Urol Oncol. 1996 Aug;14(3):122-33. Semin Urol Oncol. 1996. PMID: 8865473 Review.
420 results
Jump to page
Feedback